FDA to use Google search data to find adverse drug reactions
The deal with Google would allow the agency to look into another set of data, one that doesn't come from specific subsets of the population.
PillPack launches medication reminder app for iPhone
Available as a free download, the PillPack - Medication Reminders app promises to eliminate the frustration of remembering to take medication.
FDA says Proteus Ingestible Sensor can be used for medication adherence
When used with a medication, the Ingestible Sensor marks actual intake time, which is a quantifiable event that has allowed FDA to grant the expanded indication.
FDA, PatientsLikeMe team-up to increase patient experience of drugs in post market reviews
The FDA will get access to PatientsLikeMe's 110,000 adverse event reports on 1,000 different medications will be used as a supplement to traditional sources.
PillPack raises $50M to open new pharmacies in the U.S.
CRV led the round, with participation from Accel Partners, Atlas Venture, Menlo Ventures and Sherpa Ventures; the money will be used to fuel growth.
15-year-old launches telehealth device that can also dispense meds for seniors
Called iC LovedOnes, the product consists of a control unit and a tablet stand, with users being able to separately buy the tablet they want.
Independence Blue Cross, TowerView partner to improve medication adherence
The pilot program aims to help chronically ill people with multiple prescriptions take the right medication at the right time each day.
New Jersey Prescription Monitoring Program gets an iOS app
The program collects information on prescriptions filled in New Jersey for controlled dangerous substances (CDS) and Human Growth Hormone.
PatientsLikeMe teams-up with AstraZeneca, unveils MS study results
AstraZeneca wants to use patient-reported data from PatientsLikeMe to shape future medicine development and help improve outcomes across therapeutic areas.
ZappRx secures $5.6M Series A to expand operations
The company will use the funds to hire more people to help execute on more deals with large pharmaceutical companies.